Leerink Partnrs Has Optimistic Outlook of THC Q3 Earnings

Tenet Healthcare Co. (NYSE:THC) – Stock analysts at Leerink Partnrs lifted their Q3 2025 earnings per share estimates for Tenet Healthcare in a research note issued to investors on Tuesday, June 3rd. Leerink Partnrs analyst W. Mayo now expects that the company will earn $2.28 per share for the quarter, up from their prior forecast of $2.17. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Leerink Partnrs also issued estimates for Tenet Healthcare’s Q4 2025 earnings at $3.02 EPS, Q3 2026 earnings at $2.91 EPS, Q4 2026 earnings at $3.69 EPS, FY2026 earnings at $13.98 EPS and FY2027 earnings at $17.19 EPS.

Other equities analysts have also recently issued research reports about the company. UBS Group upped their price target on Tenet Healthcare from $217.00 to $230.00 and gave the stock a “buy” rating in a report on Wednesday, April 30th. Morgan Stanley upped their price target on Tenet Healthcare from $165.00 to $175.00 and gave the stock an “overweight” rating in a report on Monday, May 5th. Stephens raised Tenet Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. Royal Bank of Canada upped their price target on Tenet Healthcare from $183.00 to $189.00 and gave the stock an “outperform” rating in a report on Wednesday, April 30th. Finally, Guggenheim started coverage on Tenet Healthcare in a report on Wednesday, April 9th. They issued a “buy” rating and a $165.00 price target for the company. Four analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Tenet Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $180.18.

Tenet Healthcare Stock Down 0.3%

Shares of THC opened at $171.36 on Friday. Tenet Healthcare has a 52 week low of $109.82 and a 52 week high of $174.14. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25. The company has a market capitalization of $15.92 billion, a price-to-earnings ratio of 5.32, a PEG ratio of 1.02 and a beta of 1.65. The stock’s 50-day moving average price is $144.43 and its 200-day moving average price is $136.98.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Tuesday, April 29th. The company reported $4.36 EPS for the quarter, topping analysts’ consensus estimates of $3.11 by $1.25. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. The firm had revenue of $5.22 billion for the quarter, compared to the consensus estimate of $5.15 billion. During the same quarter in the prior year, the business earned $3.22 earnings per share. The company’s revenue was down 2.5% compared to the same quarter last year.

Insider Activity at Tenet Healthcare

In related news, EVP Thomas W. Arnst sold 9,786 shares of the stock in a transaction that occurred on Wednesday, May 21st. The stock was sold at an average price of $166.00, for a total value of $1,624,476.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director J Robert Kerrey sold 9,525 shares of the stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total value of $1,194,720.75. Following the completion of the sale, the director now directly owns 27,378 shares of the company’s stock, valued at approximately $3,434,022.54. This represents a 25.81% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 63,646 shares of company stock valued at $10,041,025. 0.81% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in THC. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new position in Tenet Healthcare in the first quarter worth approximately $26,000. Wayfinding Financial LLC purchased a new position in Tenet Healthcare in the first quarter worth approximately $28,000. SVB Wealth LLC purchased a new position in Tenet Healthcare in the first quarter worth approximately $30,000. Colonial Trust Co SC grew its position in Tenet Healthcare by 85.7% in the fourth quarter. Colonial Trust Co SC now owns 247 shares of the company’s stock worth $31,000 after acquiring an additional 114 shares during the period. Finally, N.E.W. Advisory Services LLC purchased a new position in Tenet Healthcare in the first quarter worth approximately $31,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.